<it>SMN1 </it>dosage analysis in spinal muscular atrophy from India
<p>Abstract</p> <p>Background</p> <p>Spinal muscular atrophy (SMA) represents the second most common fatal autosomal recessive disorder after cystic fibrosis. Due to the high carrier frequency, the burden of this genetic disorder is very heavy in developing countries li...
Main Authors: | Leonard Debra GB, Rennert Hanna, Kesari Akanchha, Mittal Balraj |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-05-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/6/22 |
Similar Items
-
Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
by: Yuri Yépez, et al.
Published: (2020-06-01) -
Analysis of dystrophin in duchenne muscular dystrophy and SMN in spinal muscular atrophy /
by: Coovert, Daniel David
Published: (1998) -
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Melissa Bowerman, et al.
Published: (2017-08-01) -
Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
by: Darija Šoltić, et al.
Published: (2020-03-01) -
Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
by: Li-Kai Tsai
Published: (2012-01-01)